Success Stories: EB-1A Approved with NAILG’s Assistance of a PhD Candidate in Biostatistics

On April 3^rd, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a PhD Candidate in the Field of Biostatistics (Approval Notice).

General Field: Biostatistics

Position at the Time of Case Filing: PhD Candidate

Country of Origin: China

State of Residence at the Time of Filing: New York

Approval Notice Date: April 3^rd, 2025

Processing Time: 1 year, 2 months, 13 days

Case Summary:

The North America Immigration Law Group (NAILG) is pleased to share the EB-1A approval of a distinguished researcher whose work sits at the intersection of biostatistics, public health, and healthcare innovation. Our client has built a reputation for addressing complex medical and societal challenges, including healthcare disparities, infectious disease treatment, and the advancement of predictive health models.

Throughout her career, she has developed novel statistical methodologies and applied them to real-world healthcare issues. Her research has contributed significantly to areas such as telemedicine, antibiotic stewardship, infectious disease modeling, and cardiovascular disease prediction. These contributions not only advance scientific understanding but also inform clinical practices and global public health policies.

Her expertise is well-documented:

She has authored 15 peer-reviewed journal articles (including 2 as first author) and contributed to 1 conference abstract.
Her work has been cited 771 times, reflecting the broad applicability and influence of her research.
She has been entrusted to conduct at least 27 peer reviews for respected journals, a recognition of her authority and leadership in the field.
Her projects were funded by leading institutions, including the National Science Foundation, Pfizer, the National Institutes of Mental Health, and the National Institutes of Health. These partnerships underscore the value of her work in driving forward both academic inquiry and practical health interventions.

As noted by one expert in the field:

“It is not difficult to see the benefits that come from a researcher as astute as [client]. Her work has implications for both the detailed application of health practices as well as the broader implementation schemes of public health, both informed by statistical analysis undertaken by [client]. In terms of the former, [client]’s work allows clinicians a better understanding of how their treatment methods work on patients, with an understanding that, for example, bedaquiline is more effective than delamind. This is important on an individual level, as it allows practitioners to prescribe a more effective drug. However, her work is not limited to the individual, as it then has significant implications for a broader picture. The World Health Organization, for instance, has implemented guidelines on the usage of bedaquiline, classifying it as a ‘Class A priority drug’ for tuberculosis patients. Global public health policy is therefore informed by [client]’s work, offering a universally-applicable finding.”

Our legal team at NAILG prepared a petition that emphasized how our client’s work has not only achieved academic distinction but also translated into meaningful, real-world outcomes. Her efforts are helping to shape a healthier, more equitable future—both in the United States and globally.

We are honored to have supported her through this important milestone and look forward to the continued impact of her research.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.